Beximco Pharmaceuticals Ltd. GDR (BXP)

Sector:

Pharma and Biotech

35.60p
   
  • Change Today:
    -0.40p
  • 52 Week High: 73.00p
  • 52 Week Low: 35.02p
  • Currency: UK Pounds
  • Shares Issued: 100.04m
  • Volume: 78
  • Market Cap: £35.61m
  • RiskGrade: 190

Latest ShareCast News

Beximco Pharmaceuticals launches fifth generic drug into US market

By Josh White

Date: Tuesday 30 Jul 2019

(Sharecast News) - Bangladesh-based generic pharmaceuticals manufacturer Beximco Pharmaceuticals has started the export of blood pressure drug 'Nadolol' to the United States market, it announced on Tuesday.

Beximco gets FDA approval for generic anti-allergy drug

By Josh White

Date: Wednesday 24 Apr 2019

(Sharecast News) - Beximco Pharmaceuticals announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for its cyproheptadine hydrochloride tablet 4mg anti-allergy drug, which is a generic equivalent to 'Periactin' 4mg tablets from Merck and Company.

Beximco adds to US portfolio with purchase of Novartis assets

By Josh White

Date: Wednesday 20 Feb 2019

(Sharecast News) - Generic drugs manufacturer Beximco Pharmaceuticals announced the signing of a definitive agreement with Sandoz - a division of Novartis - to acquire a portfolio of eight 'Abbreviated New Drug Applications' (ANDAs) in the US on Wednesday, for an undisclosed amount in cash.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

BXP Market Data

Currency UK Pounds
Price 35.60p
Change Today -0.40p
% Change -1.11 %
52 Week High 73.00p
52 Week Low 35.02p
Volume 78
Shares Issued 100.04m
Market Cap £35.61m
RiskGrade 190

BXP Dividends

  Latest Previous
  Final Final
Ex-Div 14-Nov-17 n/a
Paid 18-Jan-18 n/a
Amount 1.25 0.50

Trades for 28-May-2025

Time Volume / Share Price
08:00 78 @ 35.02p

BXP Key Personnel

Chair Ahmed Sohail Fasiur Rahman

Top of Page